P2Y 12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events.

Journal of the American College of Cardiology（2023）

引用 5|浏览52

暂无评分

摘要

Given its superior efficacy and similar overall safety, P2Y inhibitor monotherapy might be preferred over aspirin monotherapy for long-term secondary prevention in patients with established CAD. (P2Y Inhibitor or Aspirin Monotherapy as Secondary Prevention in Patients With Coronary Artery Disease: An Individual Patient Data Meta-Analysis of Randomized Trials [PANTHER collaborative initiative]; CRD42021290774).

查看译文

关键词

aspirin,coronary artery disease,meta-analysis,myocardial infarction,P2Y12 inhibitor

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要